← Leaderboards
Charles Darkoh
University Of Texas Hlth Sci Ctr Houston
$5,306,635
Attributed
$5,306,635
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $704K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,306,635 · 2
By mechanism
R01$5,306,635 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Alan W Friedman$15,114
- Lenard M Lichtenberger$8,121,394
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingHospitalsAntibioticsInsightCommunicable DiseasesClostridium DifficileRecurrencePathogenPatient PopulationPharmaceutical PreparationsTexasGenesAntibiotic TherapyBaseInfectionResistancePublic HealthDiarrheaAntibiotic-Associated DiarrheaGenetic ElementGenome SequencingCostGene ClusterGenetic
Grant awards (10)
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations$652,987
R01 · FY2025 · AI · contact PI
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations$667,987
R01 · FY2024 · AI · contact PI
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations$667,987
R01 · FY2023 · AI · contact PI
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations$703,987
R01 · FY2022 · AI · contact PI
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations$702,187
R01 · FY2021 · AI · contact PI
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infections$385,000
R01 · FY2019 · AI · contact PI
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infections$385,000
R01 · FY2018 · AI · contact PI
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infections$385,000
R01 · FY2017 · AI · contact PI
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infections$385,000
R01 · FY2016 · AI · contact PI
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infections$371,500
R01 · FY2015 · AI · contact PI